VTv Total Assets vs Total Stockholder Equity Analysis

VTVT Stock

USD 26.97 1.20 4.66%

VTv Therapeutics financial indicator trend analysis is much more than just breaking down vTv Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether vTv Therapeutics is a good investment. Please check the relationship between VTv Therapeutics Total Assets and its Total Stockholder Equity accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in vTv Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.

For more information on how to buy VTv Stock please use our How to Invest in VTv Therapeutics guide.

Total Assets vs Total Stockholder Equity

Total Assets vs Total Stockholder Equity Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of vTv Therapeutics Total Assets account and Total Stockholder Equity. At this time, the significance of the direction appears to have very week relationship.

The correlation between VTv Therapeutics' Total Assets and Total Stockholder Equity is 0.23. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Total Stockholder Equity in the same time period over historical financial statements of vTv Therapeutics, assuming nothing else is changed. The correlation between historical values of VTv Therapeutics' Total Assets and Total Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of vTv Therapeutics are associated (or correlated) with its Total Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Stockholder Equity has no effect on the direction of Total Assets i.e., VTv Therapeutics' Total Assets and Total Stockholder Equity go up and down completely randomly.

Correlation Coefficient

0.23

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Total Assets

Total assets refers to the total amount of VTv Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in vTv Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most indicators from VTv Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into vTv Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in vTv Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.

For more information on how to buy VTv Stock please use our How to Invest in VTv Therapeutics guide.At this time, VTv Therapeutics' Issuance Of Capital Stock is comparatively stable compared to the past year. Sales General And Administrative To Revenue is likely to gain to 11.59 in 2024, whereas Selling General Administrative is likely to drop slightly above 11.5 M in 2024.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	25.7M	24.6M	25.4M	26.4M
Cost Of Revenue	89K	92K	90K	85.5K

Total Operating Expenses Cost Of Revenue

VTv Therapeutics fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross
Total Assets		-0.23	0.17	-0.27	0.23	-0.25	-0.28	-0.02	-0.67	0.46	0.35	0.96	-0.34	-0.04	-0.11	-0.18	0.96	0.31	-0.2	-0.33	-0.02	-0.44	0.15	-0.12	-0.08	-0.3
Short Long Term Debt Total	-0.23		-0.64	0.96	-0.79	-0.36	0.97	-0.06	0.86	-0.34	-0.27	-0.34	0.81	0.8	-0.78	-0.19	-0.34	-0.28	0.94	-0.17	0.62	0.06	-0.28	-0.83	0.78	0.96
Other Current Liab	0.17	-0.64		-0.53	0.63	-0.03	-0.74	0.51	-0.54	0.44	0.78	0.21	-0.52	-0.43	0.58	0.1	0.21	0.5	-0.68	0.03	-0.56	-0.03	0.11	0.63	-0.62	-0.74
Total Current Liabilities	-0.27	0.96	-0.53		-0.61	-0.48	0.9	-0.11	0.86	-0.15	-0.21	-0.37	0.73	0.67	-0.63	-0.39	-0.37	-0.25	0.81	-0.17	0.39	0.13	-0.15	-0.7	0.58	0.91
Total Stockholder Equity	0.23	-0.79	0.63	-0.61		-0.1	-0.83	-0.18	-0.71	0.77	0.32	0.33	-0.75	-0.81	0.77	-0.42	0.32	0.26	-0.93	0.14	-0.96	0.07	0.56	0.85	-0.99	-0.82
Other Liab	-0.25	-0.36	-0.03	-0.48	-0.1		-0.23	0.13	-0.14	-0.64	-0.47	-0.2	-0.27	-0.26	0.36	0.72	-0.2	0.16	-0.13	-0.1	0.19	-0.44	0.01	0.24	0.06	-0.18
Property Plant And Equipment Net	-0.28	0.97	-0.74	0.9	-0.83	-0.23		-0.18	0.87	-0.47	-0.44	-0.39	0.84	0.72	-0.73	-0.1	-0.39	-0.34	0.93	-0.27	0.67	0.02	-0.22	-0.8	0.81	0.99
Current Deferred Revenue	-0.02	-0.06	0.51	-0.11	-0.18	0.13	-0.18		0.01	-0.21	0.58	-0.09	0.06	0.28	-0.02	0.48	-0.09	0.33	0.04	0.15	0.23	0.09	-0.42	-0.06	0.18	-0.19
Net Debt	-0.67	0.86	-0.54	0.86	-0.71	-0.14	0.87	0.01		-0.5	-0.37	-0.77	0.82	0.61	-0.51	-0.04	-0.77	-0.27	0.8	0.02	0.48	0.27	-0.23	-0.54	0.62	0.87
Retained Earnings	0.46	-0.34	0.44	-0.15	0.77	-0.64	-0.47	-0.21	-0.5		0.5	0.5	-0.47	-0.33	0.24	-0.75	0.5	0.2	-0.56	0.13	-0.77	0.15	0.38	0.39	-0.71	-0.48
Accounts Payable	0.35	-0.27	0.78	-0.21	0.32	-0.47	-0.44	0.58	-0.37	0.5		0.36	-0.26	0.05	0.04	-0.01	0.36	0.29	-0.31	0.14	-0.25	0.18	-0.29	0.13	-0.27	-0.47
Cash	0.96	-0.34	0.21	-0.37	0.33	-0.2	-0.39	-0.09	-0.77	0.5	0.36		-0.53	-0.13	-0.02	-0.16	1.0	0.18	-0.3	-0.28	-0.11	-0.45	0.07	-0.05	-0.19	-0.39
Non Current Assets Total	-0.34	0.81	-0.52	0.73	-0.75	-0.27	0.84	0.06	0.82	-0.47	-0.26	-0.53		0.61	-0.61	0.03	-0.53	-0.2	0.78	-0.08	0.61	0.29	-0.11	-0.6	0.72	0.8
Non Currrent Assets Other	-0.04	0.8	-0.43	0.67	-0.81	-0.26	0.72	0.28	0.61	-0.33	0.05	-0.13	0.61		-0.93	0.14	-0.13	-0.18	0.85	-0.01	0.75	0.0	-0.63	-0.88	0.82	0.71
Other Assets	-0.11	-0.78	0.58	-0.63	0.77	0.36	-0.73	-0.02	-0.51	0.24	0.04	-0.02	-0.61	-0.93		-0.04	-0.02	0.22	-0.84	0.0	-0.75	-0.01	0.53	0.89	-0.82	-0.7
Long Term Debt	-0.18	-0.19	0.1	-0.39	-0.42	0.72	-0.1	0.48	-0.04	-0.75	-0.01	-0.16	0.03	0.14	-0.04		-0.16	0.13	0.11	0.01	0.56	-0.24	-0.45	-0.06	0.4	-0.1
Cash And Short Term Investments	0.96	-0.34	0.21	-0.37	0.32	-0.2	-0.39	-0.09	-0.77	0.5	0.36	1.0	-0.53	-0.13	-0.02	-0.16		0.18	-0.3	-0.28	-0.11	-0.45	0.07	-0.05	-0.18	-0.39
Net Receivables	0.31	-0.28	0.5	-0.25	0.26	0.16	-0.34	0.33	-0.27	0.2	0.29	0.18	-0.2	-0.18	0.22	0.13	0.18		-0.27	-0.22	-0.18	-0.28	0.33	0.33	-0.22	-0.35
Common Stock Shares Outstanding	-0.2	0.94	-0.68	0.81	-0.93	-0.13	0.93	0.04	0.8	-0.56	-0.31	-0.3	0.78	0.85	-0.84	0.11	-0.3	-0.27		-0.12	0.83	-0.07	-0.43	-0.9	0.93	0.92
Short Term Investments	-0.33	-0.17	0.03	-0.17	0.14	-0.1	-0.27	0.15	0.02	0.13	0.14	-0.28	-0.08	-0.01	0.0	0.01	-0.28	-0.22	-0.12		-0.17	0.6	-0.24	0.19	-0.19	-0.3
Non Current Liabilities Total	-0.02	0.62	-0.56	0.39	-0.96	0.19	0.67	0.23	0.48	-0.77	-0.25	-0.11	0.61	0.75	-0.75	0.56	-0.11	-0.18	0.83	-0.17		-0.18	-0.58	-0.81	0.98	0.65
Inventory	-0.44	0.06	-0.03	0.13	0.07	-0.44	0.02	0.09	0.27	0.15	0.18	-0.45	0.29	0.0	-0.01	-0.24	-0.45	-0.28	-0.07	0.6	-0.18		-0.19	0.12	-0.13	-0.04
Other Current Assets	0.15	-0.28	0.11	-0.15	0.56	0.01	-0.22	-0.42	-0.23	0.38	-0.29	0.07	-0.11	-0.63	0.53	-0.45	0.07	0.33	-0.43	-0.24	-0.58	-0.19		0.53	-0.54	-0.22
Other Stockholder Equity	-0.12	-0.83	0.63	-0.7	0.85	0.24	-0.8	-0.06	-0.54	0.39	0.13	-0.05	-0.6	-0.88	0.89	-0.06	-0.05	0.33	-0.9	0.19	-0.81	0.12	0.53		-0.88	-0.8
Total Liab	-0.08	0.78	-0.62	0.58	-0.99	0.06	0.81	0.18	0.62	-0.71	-0.27	-0.19	0.72	0.82	-0.82	0.4	-0.18	-0.22	0.93	-0.19	0.98	-0.13	-0.54	-0.88		0.79
Property Plant And Equipment Gross	-0.3	0.96	-0.74	0.91	-0.82	-0.18	0.99	-0.19	0.87	-0.48	-0.47	-0.39	0.8	0.71	-0.7	-0.1	-0.39	-0.35	0.92	-0.3	0.65	-0.04	-0.22	-0.8	0.79

Click cells to compare fundamentals

VTv Therapeutics Account Relationship Matchups

VTv Therapeutics fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	9.3M	14.8M	25.5M	33.2M	11.0M	10.5M
Short Long Term Debt Total	7.1M	915K	932K	716K	529K	502.6K
Other Current Liab	4.8M	4.2M	8.1M	4.9M	6.2M	5.9M
Total Current Liabilities	13.4M	6.4M	8.5M	7.7M	10.6M	15.0M
Total Stockholder Equity	(49.0M)	(80.1M)	(9.7M)	(10.7M)	(24.7M)	(25.9M)
Other Liab	3.9M	3.9M	1.3M	19.4M	17.4M	18.3M
Property Plant And Equipment Net	1.0M	849K	680K	556K	361K	343.0K
Net Debt	5.3M	(4.8M)	(12.5M)	(11.4M)	(8.9M)	(8.5M)
Retained Earnings	(233.5M)	(290.0M)	(248.8M)	(265.5M)	(281.0M)	(295.1M)
Accounts Payable	7.1M	6.1M	8.0M	2.5M	4.1M	5.5M
Cash	1.8M	5.7M	13.4M	12.1M	9.4M	14.4M
Non Current Assets Total	6.4M	7.6M	9.9M	6.1M	361K	343.0K
Non Currrent Assets Other	2.5M	2.9M	(7.6M)	(6.1M)	(5.5M)	(5.3M)
Other Assets	4.8M	2.5M	2.9M	7.2M	8.3M	8.7M
Cash And Short Term Investments	1.8M	5.7M	13.4M	12.1M	9.4M	14.4M
Net Receivables	5K	158K	57K	12.4M	102K	96.9K
Common Stock Shares Outstanding	757.3K	1.2M	1.5M	1.9M	2.1M	2.0M
Short Term Investments	250K	371K	100K	15K	65K	61.8K
Liabilities And Stockholders Equity	9.3M	14.8M	25.5M	33.2M	11.0M	10.5M
Non Current Liabilities Total	44.9M	88.5M	26.7M	36.3M	18.9M	18.0M
Other Current Assets	806K	939K	2.0M	2.5M	1.1M	1.1M
Other Stockholder Equity	183.9M	209.2M	238.2M	253.7M	256.3M	163.5M
Total Liab	58.3M	94.9M	35.2M	44.0M	29.6M	28.1M
Property Plant And Equipment Gross	1.0M	367K	680K	556K	848K	1.1M
Total Current Assets	2.8M	7.2M	15.6M	27.1M	10.7M	16.9M
Short Term Debt	6.3M	239K	440K	378K	360K	342K
Property Plant Equipment	1.0M	367K	680K	207K	186.3K	177.0K
Net Tangible Assets	(49.0M)	3.8M	(9.7M)	5.8M	6.7M	7.1M
Short Long Term Debt	6.2M	84K	256K	224K	191K	181.5K
Common Stock Total Equity	435K	641K	541K	1.0M	1.2M	1.3M
Capital Surpluse	150.6M	183.9M	209.2M	253.7M	291.8M	183.4M

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards VTv Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, VTv Therapeutics' short interest history, or implied volatility extrapolated from VTv Therapeutics options trading.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

GM	General Motors
S	SentinelOne
MSFT	Microsoft

When determining whether vTv Therapeutics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if VTv Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Vtv Therapeutics Stock. Highlighted below are key reports to facilitate an investment decision about Vtv Therapeutics Stock:

How To Invest In VTv

Details

Is VTv Stock a good investment?

Details

What is VTv Therapeutics' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in vTv Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.

For more information on how to buy VTv Stock please use our How to Invest in VTv Therapeutics guide.

You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Complementary Tools for VTv Stock analysis

When running VTv Therapeutics' price analysis, check to measure VTv Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VTv Therapeutics is operating at the current time. Most of VTv Therapeutics' value examination focuses on studying past and present price action to predict the probability of VTv Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VTv Therapeutics' price. Additionally, you may evaluate how the addition of VTv Therapeutics to your portfolios can decrease your overall portfolio volatility.

	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios
	Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios
	Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market.
	Analyst Advice Analyst recommendations and target price estimates broken down by several categories

Is VTv Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of VTv Therapeutics. If investors know VTv will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about VTv Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(9.71)

Revenue Per Share

0.004

Return On Assets

(0.72)

Return On Equity

(49.78)

The market value of vTv Therapeutics is measured differently than its book value, which is the value of VTv that is recorded on the company's balance sheet. Investors also form their own opinion of VTv Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is VTv Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VTv Therapeutics' market value can be influenced by many factors that don't directly affect VTv Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between VTv Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if VTv Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VTv Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

VTv Total Assets vs Total Stockholder Equity Analysis

Total Assets vs Total Stockholder Equity

Total Assets vs Total Stockholder Equity Correlation Analysis

Correlation Coefficient

Total Assets

Total Stockholder Equity

VTv Therapeutics fundamental ratios Correlations

VTv Therapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

VTv Therapeutics fundamental ratios Accounts

Also Currently Popular

Complementary Tools for VTv Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Property Plant And Equipment Gross	+ 0.99	Property Plant And Equipment Net
Total Liab	+ 0.98	Non Current Liabilities Total
Property Plant And Equipment Net	+ 0.97	Short Long Term Debt Total
Cash	+ 0.96	Total Assets
Cash And Short Term Investments	+ 0.96	Total Assets

Total Liab	- 0.99	Total Stockholder Equity
Non Current Liabilities Total	- 0.96	Total Stockholder Equity
Other Assets	- 0.93	Non Currrent Assets Other
Common Stock Shares Outstanding	- 0.93	Total Stockholder Equity
Other Stockholder Equity	- 0.9	Common Stock Shares Outstanding
Total Liab	- 0.88	Other Stockholder Equity